Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BioGeometry logo — Where Protein Design Meets Generative AI and Geometric Deep...

BioGeometry

Where Protein Design Meets Generative AI and Geometric Deep Learning.

Founded 2022 China Beijing, China 10 employees Series A Total: $200.00M Biotechnology

General Information

Company Name BioGeometry
Founded Year 2022
Location China Beijing, China +1
Employees 10
Industries Biotechnology
Funding Stage Series A
Social

Get notified when BioGeometry moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

BioGeometry recently secured a substantial CNY200.00M Series A funding round, demonstrating strong investor confidence in its AI-driven protein design platform. This significant capital injection, supported by repeat investor Gaorong Capital, is set to rapidly accelerate the development of their next-generation programmable protein medicines. This strategic shift underscores an intensified focus on R&D and scaling their innovative therapeutic solutions.

Signal Types
Funding
Strategic Labels
Series A Funding Biotech R&D AI Innovation
Next Move: Hiring
·
Impact: 9/10
·
Ideal For: AI Biotech Investors — Growth Stage

About BioGeometry

BioGeometry, founded in 2022, is an innovative player in the Biotechnology industry. Its slogan, "Where Protein Design Meets Generative AI and Geometric Deep Learning," encapsulates its cutting-edge approach to developing programmable protein medicines.

The company uniquely tackles the longstanding issues of high costs, lengthy development cycles, and low success rates in traditional macromolecular therapeutics. By integrating geometric deep learning, structural biology, immunology, and synthetic biology, BioGeometry leverages a blend of AI capabilities and biological insights.

The team comprises talents from prestigious pharmaceutical firms and top-tier AI and bio labs globally, indicating a robust foundation in both scientific and technological expertise.

Notably, on 01 June 2026, they secured a substantial CNY200.00M Series A investment from prominent backers Gaorong Capital, Anxin Capital, and Fortune Venture. This significant funding underscores investor confidence in their pioneering approach and growth potential.

Taxonomy: Protein Design, Generative AI, Geometric Deep Learning, Programmable Medicines, Biotech Innovations, Structural Biology, Immunology, Synthetic Biology, Macromolecular Therapeutics, AI-driven Biotech, Biopharmaceutical R&D, Next-gen Therapies, Therapeutic Optimization, Technology-driven Drug Development, Biological Data Analysis

Services & Products

Generative AI solutions for protein design
Development of next-generation biologics
Bio-manufacturing solutions
Enzyme optimization technologies
Epitope-specific antibody generation

Target Customers

Biopharmaceutical companies Synthetic biology companies Research institutions focusing on drug development Organizations working on sustainable solutions

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 3
Investor Investor
•••• •••• 		01 Jun 2026
Seed •••••• 4
Investor Investor
•••• •••• 		01 Jun 2024
Seed •••••• 1
Investor
01 Sep 2022
Spinout •••••• 2
Investor
•••• •••• 		01 Jan 2022

BioGeometry Alternatives & Competitors

BioGeometry vs
Sentegen Biotech
Sentegen Biotech Turkey

Creating innovative synthetic biology solutions in English.

2-10 employees
Biotechnology, Deep Tech
BioGeometry vs
Kisker Biotech GmbH & Co. KG
Kisker Biotech GmbH & Co. KG

Supplying you the best consumables and equipment !

8 employees
Biotechnology, E-Commerce
BioGeometry vs
Bainom
Bainom United States

Unlocking clinical insights by decoding intricate multi-omic patterns.

Pre Seed
2 employees
AI, Analytics

FAQ About BioGeometry

Where Protein Design Meets Generative AI and Geometric Deep Learning.
BioGeometry was founded in 2022.
BioGeometry is headquartered in Beijing, China.
BioGeometry operates in the following industries: Biotechnology.
BioGeometry has approximately 10 employees.
BioGeometry has completed 4 funding rounds, raising a total of $200.00M. The latest funding stage is Series A.
BioGeometry offers: Generative AI solutions for protein design, Development of next-generation biologics, Bio-manufacturing solutions, Enzyme optimization technologies, Epitope-specific antibody generation.
Top alternatives and competitors to BioGeometry include Sentegen Biotech, Kisker Biotech GmbH & Co. KG, Bainom, Prolific Machines, Coding Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioGeometry and Sentegen Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioGeometry and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy